Description | This product is an antagonist antibody against human TSLPR. The mAb is a chimeric anti-hTSLPR antibody. It was found to be able to inhibit activities mediated by TSLP signaling. |
Clonality | Monoclonal |
Host Species | Human |
Target Species | Human |
Isotype | IgG1 |
Expression Species | HEK293F or CHO |
Conjugation | None |
Purity | >95%, determined by SDS-PAGE and SEC-HPLC |
Endotoxin | <1 EU/mg |
Purification | Protein A affinity purified |
Sterility | 0.2 μM filtered |
Formulation | PBS, pH 7.4 |
Preservation | No preservatives |
Stabilizer | No stabilizers |
Storage | Store at 4°C within a week. For longer storage, aliquot and store at -20°C. |
Application | Antagonist; ELISA; FC; Inhib |
Application Notes | The antibody is recommended for detection of CRLF2 by Antagonist, ELISA, FC, Inhib assays. |
ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
WB | Western Blot Protocol |
FC | Flow Cytometry Protocol |
Target | CRLF2 |
Alternative Name | CRL2; TSLPR; CRLF2Y; cytokine receptor-like factor 2; IL-XR; TSLP receptor; cytokine receptor CRL2 precusor; thymic stromal lymphopoietin protein receptor; thymic stromal-derived lymphopoietin receptor |
Gene ID | 64109 |
UniProt | Q9HC73 |
Related pathway | STAT3, STAT5, and JAK2 pathways |